liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Quality of life is impaired similarly in heart failure patients with preserved and reduced ejection fraction
University of Groningen.
University of Groningen.
University of Groningen.
University of Groningen.
Show others and affiliations
2011 (English)In: European Journal of Heart Failure, ISSN 1388-9842, E-ISSN 1879-0844, Vol. 13, no 9, 1013-1018 p.Article in journal (Refereed) Published
Abstract [en]

Aims To compare quality of life (QoL) in heart failure (HF) patients with preserved ejection fraction (HF-PEF) and HF patients with reduced ejection fraction (HF-REF) in a well-defined HF population. less thanbrgreater than less thanbrgreater thanMethods and results Patients with HF-PEF [left ventricular ejection fraction (LVEF) andgt;= 40%] were matched by age and gender to patients with HF-REF (LVEF,40%). In the current study, we only included HF patients with a B-type natriuretic peptide level (BNP) andgt; 100 pg/mL. Quality of life was assessed by Cantrils Ladder of Life, RAND-36, and the Minnesota Living with Heart Failure questionnaire, and impairment of QoL was adjusted for by BNP as a marker for severity of HF. We examined a total of 290 HF patients, of whom 145 had HF-PEF (41% female; age 72 +/- 10; LVEF 51 +/- 8%) and 145 had HF-REF (41% female; age 73 +/- 10, LVEF 26 +/- 7%). All HF patients reported markedly low scores of QoL, both on the general and disease-specific QoL questionnaires. Quality of life between patients with HF-PEF and HF-REF did not differ significantly. When adjusting the QoL scores for BNP, an association between QoL and LVEF was not found, i.e. patients with HF-PEF and HF-REF with similar BNP levels had the same impairment in QoL. less thanbrgreater than less thanbrgreater thanConclusion Quality of life is similarly impaired in patients with HF-PEF as in HF-REF. These findings further support the need for more pharmacological and non-pharmacological studies in patients with HF-PEF.

Place, publisher, year, edition, pages
Oxford University Press (OUP) , 2011. Vol. 13, no 9, 1013-1018 p.
Keyword [en]
Heart failure, Quality of life, Preserved ejection fraction, Reduced ejection fraction, B-type Natriuretic Peptide
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-70519DOI: 10.1093/eurjhf/hfr072ISI: 000294070800014OAI: diva2:440107
|Biosite Europe||Amgen||Pfizer||Medtronic||Biotronic||Alere||Vifor||Available from: 2011-09-12 Created: 2011-09-12 Last updated: 2011-09-20

Open Access in DiVA

fulltext(306 kB)463 downloads
File information
File name FULLTEXT01.pdfFile size 306 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Search in DiVA

By author/editor
Jaarsma, Tiny
By organisation
Health, Activity, CareFaculty of Health Sciences
In the same journal
European Journal of Heart Failure
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 463 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 267 hits
ReferencesLink to record
Permanent link

Direct link